FrancophonIA/ELRC3.0 huggingface dataset:
English: It must be injected very slowly over a period of 5 minutes.
Croatian: Lijek se mora injicirati vrlo sporo tijekom perioda od 5 minuta.
English: • Patients with methaemoglobinaemia due to chlorate poisoning
Croatian: • Bolesnici s methemoglobinemijom zbog trovanja kloratom
English: Methylthioninium chloride is a potent inhibitor of the transporters OCT2, MATE1 and MATE2-K.
Croatian: Metiltioninijev klorid snažan je inhibitor transportera OCT2, MATE1 i MATE2-K.
English: The administration of methylthioninium chloride Proveblue has the potential to transiently increase or decrease the clearance of drugs that are primarily metabolized by these enzymes.
Croatian: Primjena lijeka Methylthioninium chloride Proveblue može prolazno povećati ili smanjiti klirens lijekova koji se prvenstveno metaboliziraju ovim enzimima.
English: Adverse reactions, seen at exposure levels similar to clinical exposure levels and with possible relevance to clinical use were moderate regenerative anaemia associated with increased mean platelet count and fibrinogen levels, a minimal increase in mean total bilirubin blood values and an increased incidence of moderate urine bilirubin levels.
Croatian: Nuspojave, viđene na razinama izloženosti sličnim kliničkim razinama izloženosti i uz mogući značaj za kliničku primjenu su bile umjerena regenerativna anemija povezana s povišenjem srednje vrijednosti broja trombocita i razina fibrinogena, malo povišenje srednjih vrijenosti razina bilirubina u krvi i povećanje incidencije umjerenih razina bilirubina u mokraći.
English: Cenexi 52, Rue Marcel et Jacques Gaucher, 94120 Fontenay-sous-Bois, France
Croatian: Cenexi 52, Rue Marcel et Jacques Gaucher, 94120 Fontenay-sous-Bois, Francuska
English: You must not be given Methylthioninium chloride Proveblue: - if you are allergic to methylthioninium chloride or other thiazine dyes - if your body does not produce enough of the enzyme G6PD (glucose-6-phosphate dehydrogenase) - if your body does not produce enough of the enzyme NADPH (nicotinamide adenine dinucleotide phosphate) reductase - if your blood disorder has been caused by nitrite during treatment of cyanide poisoning - if your blood disorder has been caused by chlorate poisoning.
Croatian: Ne smijete primiti Methylthioninium chloride Proveblue: - ako ste alergični na metiltioninijev klorid ili druge tiazinske boje - ako Vaše tijelo ne stvara dovoljno enzima G6PD (glukoza-6-fosfat dehidrogenaza) - ako Vaše tijelo ne stvara dovoljno enzima NADPH (nikotinamid adenin dinukleotid fosfat)
English: Methylthioninium chloride Proveblue is not an in vitro substrate for BCRP or OCT2 and is not an in vitro inhibitor of BCRP, OAT1 or OAT3.
Croatian: Methylthioninium chloride Proveblue nije in vitro supstrat za BCRP ili OCT2 i nije in vitro inhibitor BCRP, OAT1 ili OAT3.
English: Individuals without methaemoglobinaemia
Croatian: Osobe bez methemoglobinemije
English: What Methylthioninium chloride Proveblue is and what it is used for
Croatian: Što je Methylthioninium chloride Proveblue i za što se koristi
English: Caution should be exercised in the course of treatment with methylthioninium chloride as this may exacerbate Heinz body formation and haemolytic anaemia.
Croatian: Nužan je oprez tijekom liječenja metiltioninijevim kloridom jer može pogoršati formiranje Heinzovih tijela i hemolitičke anemije.
English: When used in combination with these medicines methylthioninium chloride may cause serotonin syndrome, which can be potentially life-threatening.
Croatian: Kada se koristi u kombinaciji s tim lijekovima, metiltioninijev klorid može izazvati serotoninski sindrom koji može biti opasan po život.
English: Type I glass ampoules.
Croatian: Ampule od stakla tipa I.
English: In cases of suspected methaemoglobinaemia, it is advisable to check the oxygen saturation by cooximetry when available since pulse oximetry may provide a false estimation of oxygen saturation during administration of methylthioninium chloride.
Croatian: U slučajevima sumnje na methemoglobinemiju, savjetuje se provjeriti zasićenost kisikom putem kooksimetrije, ako je moguće, jer tijekom primjene metiltioninijeva klorida, pulsna oksimetrija može dati pogrešnu procjenu zasićenosti kisikom.
English: • Patients with nitrite-induced methaemoglobinaemia during treatment of cyanide poisoning
Croatian: • Bolesnici s methemoglobinemijom uzrokovanom nitritom tijekom liječenja trovanja cijanidom
English: What Methylthioninium chloride Proveblue looks like and contents of the pack Methylthioninium chloride Proveblue is a clear dark blue solution for injection (injection) and is supplied in clear glass ampoules.
Croatian: Kako Methylthioninium chloride Proveblue izgleda i sadržaj pakiranja Methylthioninium chloride Proveblue je bistra tamnoplava otopina za injekciju (injekcija) i isporučuje se u prozirnim staklenim ampulama.
English: In patients with aniline-induced methaemoglobinaemia, repeated doses of methylthioninium chloride may be required.
Croatian: U bolesnika s methemoglobinemijom izazvanom anilinom mogu biti potrebne ponovljene doze metiltioninijeva klorida.
English: • buspirone
Croatian: • buspiron
English: Anaesthesiologists should be vigilant for methaemoglobinaemia in patients receiving dapsone therapy and for BIS (Bispectral Index) interference with Methylthioninium chloride Proveblue administration.
Croatian: Anesteziolozi moraju obratiti posebnu pozornost na methemoglobinemiju u bolesnika koji primaju terapiju dapsona i interferenciju BIS-a (bispektralni indeks) tijekom primjene Methylthioninium chloride Proveblue.
English: Failure to respond to methylthioninium chloride suggests cytochrome b5 reductase deficiency, glucose6- phosphate dehydrogenase deficiency or sulfhaemoglobinemia.
Croatian: Nedostatak reakcije na metiltioninijev klorid ukazuje na pomanjkanje citokrom-b5-reduktaze, pomanjkanje glukoza-6-fosfat-dehidrogenaze ili sulfhemoglobinemiju.
English: Cumulative doses of Methylthioninium chloride may lead to dyspnoea and tachypnoea, presumably related to reduced oxygen availability caused by methaemoglobinaemia, chest pain, tremor, cyanosis and haemolytic anaemia.
Croatian: Kumulativne doze metiltioninijeva klorida mogu dovesti do dispneje i tahipneje, koje su vjerojatno povezane sa smanjenom dostupnosti kisika uzrokovanom methemoglobinemijom, do boli u prsištu, tremora, cijanoze i hemolitičke anemije.
English: It is recommended not to exceed a cumulative dose for the course of treatment of 4 mg/kg in patients with dapsone-induced methaemoglobinaemia.
Croatian: Tijekom liječenja ne preporučuje se prekoračenje kumulativne doze od 4 mg/kg u bolesnika s methemoglobinemijom izazvanom dapsonom.
English: Haemolytic anaemia
Croatian: Nepoznato hemolitička anemija
English: In vitro, methylthioninium chloride has been shown to reduce motility of human sperm in a dose dependant manner.
Croatian: In vitro, metiltioninijev klorid je pokazao da smanjuje pokretljivost ljudskih spermija ovisno o dozi.
English: The administration of methylthioninium chloride Proveblue has the potential to transiently increase the exposure of drugs primarily cleared by renal transport involving the OCT2/MATE pathway, including cimetidine, metformin and acyclovir.
Croatian: Primjena lijeka Methylthioninium chloride Proveblue može prolazno povećati izloženost lijekovima koji se prvenstveno eliminiraju putem bubrega, transportom koji uključuje OCT2/MATE put, uključujući cimetidin, metformin i aciklovir.
English: Methylthioninium chloride Proveblue should not be used during pregnancy unless clearly necessary, e.g. in life-threatening methaemoglobinaemia.
Croatian: Methylthioninium chloride Proveblue ne smije se primjenjivati tijekom trudnoće, osim ako je to neophodno, npr. u slučaju methemoglobinemije opasne po život.
English: It must especially not be mixed with sodium chloride 9 mg/ml (0.9%) solution for injection because it has been demonstrated that chloride reduces the solubility of methylthioninium chloride.
Croatian: Osobito se ne smije miješati s otopinom natrijevog klorida 9 mg/ml (0,9 %) za injekcije jer je dokazano da kloridi smanjuju topljivost metiltioninijeva klorida.
English: No evidence of carcinogenic activity was observed in female rats.
Croatian: Nije opažen dokaz kancerogene aktivnosti u ženki štakora.
English: Methylthioninium chloride is a substrate of P-glycoprotein (P-gp).
Croatian: Metiltioninijev klorid supstrat je P-glikoproteina (P-gp).
English: Methylthioninium chloride may cause a photosensitivity reaction in the skin (sunburn-like reaction) when exposed to strong light sources, such as light therapy, lights in operating rooms and pulse oximeters.
Croatian: Metiltioninijev klorid može izazvati reakciju fotosenzitivnosti na koži (reakciju sličnu opeklinama od sunca) prilikom izlaganja izvorima snažnog svjetla, kao što je terapija svjetlom, svjetla u operacijskim salama i svjetla pulsnih oksimetara.
English: If you are given more Methylthioninium chloride Proveblue than you should As this medicine will be given to you whilst you are in hospital, it is unlikely that you will be given too much or too little, however, tell your doctor if you notice one of the following adverse reactions: - feeling sick, - stomach pain, - chest pain, - dizziness, - headache, - sweating, - confusion, - an increase in methaemoglobin (an abnormal form of haemoglobin in the blood), - high blood pressure, - shortness of breath, - abnormally fast beating of the heart, - tremor, - skin discolouration.
Croatian: S obzirom na to da ćete ovaj lijek primati dok ste u bolnici, malo je vjerojatno da ćete primiti previše ili premalo lijeka, ali ipak, recite liječniku ako primijetite jednu od sljedećih nuspojava: - mučnina, - bol u trbuhu, - bol u prsištu, - omaglicu, - glavobolju, - znojenje, - smetenost, - povišenje methemoglobina (nenormalan oblik hemoglobina u krvi), - povišen krvni tlak, - nedostatak zraka, - nenormalno brzo kucanje srca, - tremor, - promjena boje kože.
English: Individuals with methaemoglobinaemia
Croatian: Osobe s methemoglobinemijom
English: What you need to know before you are given Methylthioninium chloride Proveblue
Croatian: Što morate znati prije nego primite Methylthioninium chloride Proveblue
English: Methylthioninium chloride Proveblue is not an in vitro inducer of CYP2B6 and CYP3A4.
Croatian: Methylthioninium chloride Proveblue nije in vitro induktor CYP2B6 i CYP3A4.
English: Patients treated with methylthioninium chloride in combination with serotonergic drugs should be monitored for the emergence of serotonin syndrome.
Croatian: Bolesnike koji se liječe metiltioninijevim kloridom u kombinaciji sa serotonergičkim lijekovima treba pratiti zbog moguće pojave serotoninskog sindroma.
English: Methylthioninium chloride has moderate influence on the ability to drive and use machines.
Croatian: Metiltioninijev klorid umjereno utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: A repeat dose (0.3 to 0.5 mg/kg body weight, i.e. 0.06-0.1 ml/kg body weight) may be given one hour after the first dose in cases of persistent or recurrent symptoms or if methaemoglobin levels remain significantly higher than the normal clinical range (see section 4.4 for important safety information).
Croatian: Ponovljenu dozu (0,3 do 0,5 mg/kg tjelesne težine, tj. 0,06 do 0,1 ml/kg tjelesne težine) moguće je primijeniti jedan sat nakon prve doze u slučajevima perzistentnih ili rekurentnih simptoma ili ako su razine methemoglobina ostanu znatno više od normalnog kliničkog raspona (za važne informacije o sigurnosti vidjeti dio 4.4).
English: It must not be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection because it has been demonstrated that chloride reduces the solubility of methylthioninium chloride.
Croatian: Ne smije se razrjeđivati s otopinom natrijevog klorida 9 mg/ml (0,9%) za injekcije jer je dokazano da kloridi smanjuju topljivost metiltioninijeva klorida.
English: A repeat dose (0.3 to 0.5 mg/kg body weight, i.e. 0.06-0.1 ml/kg) may be given after one hour in case of persistence or recurrence of symptoms.
Croatian: Ponovljenu dozu (0,3 do 0,5 mg/kg tjelesne težine, tj. 0,06-0,1 ml/kg) moguće je dati nakon jedan sat u slučaju neprestajanja ili ponovne pojave simptoma.
English: Electrocardiogram (ECG) and blood pressure should be monitored during and after treatment with Methylthioninium chloride Proveblue as hypotension and cardiac arrhythmia are potential adverse reactions (see section 4.8).
Croatian: Tijekom i nakon liječenja lijekom Methylthioninium chloride Proveblue potrebno je praćenje elektrokardiograma (EKG-a) i krvnog tlaka jer su hipotenzija i srčana aritmija potencijalne nuspojave (vidjeti dio 4.8).
English: Do not use Methylthioninium chloride Proveblue if the solution is discoloured, cloudy, turbid, or a precipitate or particles are present.
Croatian: Nemojte koristiti Methylthioninium chloride Proveblue ako je otopina promijenila boju, ako je zamućena, zamagljena, ili ako su prisutni talog ili čestice.
English: Methylthioninium chloride Proveblue is an in vitro inhibitor of P-gp.
Croatian: Methylthioninium chloride Proveblue je in vitro inhibitor P-gp-a.
English: • Very common side effects (may affect more than 1 in 10 people) pain in extremity dizziness sweating skin discolouration.
Croatian: • Vrlo česte nuspojave (mogu se javiti u više od 1 na 10 osoba): - bol u udu - omaglica - znojenje - promjena boje kože.
English: A repeat dose (1 to 2 mg/kg body weight, i.e. 0.2-0.4 ml/kg body weight) may be given one hour after the first dose in cases of persistent or recurrent symptoms or if methaemoglobin levels remain significantly higher than the normal clinical range.
Croatian: Ponovljenu dozu (1 do 2 mg/kg tjelesne težine, tj. 0,2-0,4 ml/kg tjelesne težine) moguće je primijeniti jedan sat nakon prve doze u slučajevima perzistentnih ili rekurentnih simptoma ili ako razine methemoglobina ostanu znatno više od normalnog kliničkog raspona.
English: Monitoring tests You will undergo monitoring tests during and after treatment with Methylthioninium chloride Proveblue.
Croatian: Proći ćete testove tijekom i nakon liječenja lijekom Methylthioninium chloride Proveblue.
English: Methylthioninium chloride may cause a cutaneous photosensitivity reaction when exposed to strong light sources, such as phototherapy, those found in operating theatres or locally from illuminating devices such as pulse oximeters.
Croatian: Metiltioninijev klorid može izazvati reakciju fotosenzitivnosti na koži prilikom izlaganja izvorima jakog svjetla, kao što su fototerapija, izvori svjetla u operacijskim dvoranama ili lokalno iz svjetlećih uređaja kao što su pulsni oksimetri.
English: Methylthioninium chloride should be used with caution in patients with moderate to severe renal disease since there is limited data available and methylthioninium chloride is predominantly renally eliminated.
Croatian: Metiltioninijev klorid treba oprezno primjenjivati u bolesnika s umjerenom do teškom bolesti bubrega zbog ograničenih podataka i jer se metiltioninijev klorid uglavnom eliminira putem bubrega.
English: What Methylthioninium chloride Proveblue contains - The active substance is methylthioninium chloride.
Croatian: Što Methylthioninium chloride Proveblue sadrži - Djelatna tvar je metiltioninijev klorid.
English: Warnings and precautions Talk to your doctor or nurse before you are given Methylthioninium chloride Proveblue - if you have moderate or severe renal disease; lower doses (< 1 mg/kg) may be needed - if your blood disorder has been caused by a chemical called aniline, which is contained in dyes; lower doses may be needed and total cumulative dose should not exceed 4 mg/kg (see section 3 of this package leaflet) - if your blood disorder has been caused by a medicine called dapsone (used to treat leprosy and other skin conditions); lower doses may be needed and total cumulative dose should not exceed 4 mg/kg (see section 3)
Croatian: Obratite se svom liječniku ili medicinskoj sestri prije nego primite Methylthioninium chloride Proveblue: - ako imate umjerenu ili tešku bolest bubrega, niže doze (< 1 mg/kg) možda budu potrebne - ako je Vaš poremećaj krvi uzrokovan kemikalijom koja se zove anilin, koja je sadržana u bojama; možda budu potrebne niže doze i ukupna kumulativna doza ne smije prijeći 4 mg/kg
English: Not known (frequency cannot be estimated from the available data): - serotonin syndrome when Methylthioninium chloride Proveblue has been taken with certain medicines to treat depression or anxiety, see section 2 - decreased haemoglobin (protein in red blood cells that carry oxygen in the blood) levels may be reported during blood tests - reduction in red blood cells which may turn your skin pale and make you breathless and weak - local tissue damage at the injection site - jaundice (yellowing of the skin and eyes) - this has only been reported in infants - problems with speech - high or low blood pressure - agitation - lack of oxygen - irregular heartbeat, including an abnormally slow or fast beating of the heart - severe allergic reactions (so called anaphylactic reaction which may cause your throat or face to swell, difficulty breathing or a severe rash) - an increase in methaemoglobin (an abnormal form of haemoglobin in the blood) - shortness of breath - confusion - shaking - hives - fever - rapid breathing - dilated pupils - discoloured stools.
Croatian: mogu biti zabilježene tijekom obavljanja pretraga krvi - smanjenje broja crvenih krvnih stanica zbog čega možete imati blijedu kožu, nedostatak zraka i slabost - lokalno oštećenje tkiva na mjestu injekcije - žutica (žutilo kože i očiju) - prijavljena je samo kod dojenčadi - problemi s govorom - povišen ili snižen krvni tlak - uznemirenost - nedostatak kisika - nepravilni otkucaji srca, uključujući i nenormalno spore ili brze otkucaje srca - teške alergijske reakcije (takozvana anafilaktička reakcija koja može uzrokovati oticanje grla ili lica, otežano disanje ili jaki osip) - povećanje methemoglobina (nenormalan oblik hemoglobina u krvi) - nedostatak zraka - smetenost - tresenje - koprivnjača - vrućica - ubrzano disanje - proširene zjenice - promjena boje stolice.
English: Additional information on how Methylthioninium chloride Proveblue can be given is provided in section 3 of the Package Leaflet.
Croatian: Dodatne informacije o tome kako se Methylthioninium chloride Proveblue primjenjuje su dane u dijelu 3 ove upute o lijeku.
English: • venlafaxine
Croatian: • venlafaksin
English: Blood and lymphatic system disorders
Croatian: Poremećaji krvi i limfnog sustava methemoglobinemija
English: It is unknown whether methylthioninium chloride is excreted in human breast milk.
Croatian: Nije poznato izlučuje li se metiltioninijev klorid u majčino mlijeko u ljudi.
English: Hyperbilirubinaemia has been observed in infants after administration of 20 mg/kg methylthioninium chloride.
Croatian: Hiperbilirubinemija je primijećena kod dojenčadi nakon primjene metiltioninijeva klorida od 20 mg/kg.
English: 22 rue Marc Donadille, 13013 Marseille, France
Croatian: 22 rue Marc Donadille, 13013 Marseille, Francuska
English: If diluted in glucose 50 mg/ml (5%) solution for injection, methylthioninium chloride must be used with caution in patients with hyperglycaemia or diabetes mellitus, as these conditions may be exacerbated by the glucose solution.
Croatian: Ako se metiltioninijev klorid koristi razrijeđen u otopini glukoze za injekcije 50 mg/ml (5%), potreban je oprez kod primjene u bolesnika s hiperglikemijom ili šećernom bolesti jer otopina glukoze može pogoršati ta stanja.
English: Local tissue necrosis at the injection site Not known Injection site pain
Croatian: Često mjestu primjene lokalna nekroza tkiva na mjestu injiciranja
English: Eye disorders
Croatian: Poremećaji oka midrijaza
English: Methylthioninium chloride Proveblue has been observed to stain tissues selectively.
Croatian: Opaženo je da Methylthioninium chloride Proveblue selektivno boji tkivo.
English: How to store Methylthioninium chloride Proveblue
Croatian: Kako čuvati Methylthioninium chloride Proveblue
English: Its use in parathyroid surgery (not indicated) has induced adverse CNS effects when administered concomitantly with serotonergic medicinal products (see section 4.5).
Croatian: Njegova primjena uz istodobnu primjenu serotoninergičkih lijekova kod operacija paratireoidnih žlijezda (nije indiciran) izazvala je negativne nuspojave na SŽS-u (vidjeti dio 4.5).
English: Hyperbilirubinaemia
Croatian: Nepoznato hiperbilirubinemija
English: This medicine may be diluted in 50 ml glucose 50 mg/ml (5%) solution for injection to avoid local pain, in particular in children.
Croatian: Ovaj lijek može se razrijediti u 50 ml otopine glukoze za injekcije 50 mg/ml (5%) da bi se izbjegla lokalna bol, osobito kod djece.
English: For single use only Any solution remaining in the opened ampoules must be discarded.
Croatian: Neupotrebljenu otopinu iz otvorenih ampula potrebno je zbrinuti.
English: An equivocal evidence of carcinogenic activity was observed in female mice.
Croatian: Nisu opaženi pouzdani dokazi o kancerogenoj aktivnosti u ženki miševa.
English: Each 10 ml ampoule contains 50 mg methylthioninium chloride Each 2 ml ampoule contains 10 mg methylthioninium chloride
Croatian: Jedna ampula od 10 ml sadrži 50 mg metiltioninijeva klorida Jedna ampula od 2 ml sadrži 10 mg metiltioninijeva klorida
English: Methylthioninium chloride is an in vitro inducer of CYP1A2.
Croatian: Metiltioninijev klorid je in vitro induktor CYP1A2.
English: PROVEPHARM SAS 22 rue Marc Donadille, 13013 Marseille, France
Croatian: Provepharm SAS 22 rue Marc Donadille, 13013 Marseille, Francuska
English: Provepharm SAS 22 rue Marc Donadille, 13013 Marseille, France
Croatian: PROVEPHARM SAS 22 rue Marc Donadille, 13013 Marseille, Francuska
English: Death occurred in 2 infants after administration of 20 mg/kg methylthioninium chloride.
Croatian: Kod 2 dojenčeta je došlo do smrti nakon primjene metiltioninijeva klorida od 20 mg/kg.
English: Each carton contains a tray with 5 or 20 ampoules of 2 ml in blister.
Croatian: Jedna kutija sadrži podložak s 5 ili 20 ampula od 2 ml u blisteru.
English: Methylthioninium chloride Proveblue is for administration by a healthcare professional.
Croatian: Methylthioninium chloride Proveblue smije primjenjivati samo zdravstveni radnik.
English: The recommended dose is 0.3 to 0.5 mg/kg body weight, i.e. 0.06 to 0.1 ml/kg, over a period of 5 minutes.
Croatian: Preporučena doza je 0,3 do 0,5 mg/kg tjelesne težine, tj. 0,06 do 0,1 ml/kg, u trajanju od 5 minuta.
English: Haemodialysis may be used in patients with severe haemolysis.
Croatian: U bolesnika s teškom hemolizom može se primijeniti hemodijaliza.
English: Each box contains a tray with 20 ampoules of 2 ml.
Croatian: Jedna kutija sadrži podložak s 20 ampula od 2 ml.
English: Skin discoloration (blue)
Croatian: Poremećaji kože i potkožnog tkiva promjena boje kože (plava)
English: Faeces discoloration (blue-green)
Croatian: Poremećaji bubrega i mokraćnog sustava kromaturija (plavo-zelena)
English: Musculoskeletal and connective tissue disorder
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva bol u ekstremitetu
English: The recommended dose is 0.3-0.5 mg/kg body weight, i.e. 0.06 to 0.1 ml/kg body weight, given over a period of 5 minutes.
Croatian: Preporučena doza je 0,3-0,5 mg/kg tjelesne težine, tj. 0,06 do 0,1 ml/kg tjelesne težine, primijenjena u periodu od 5 minuta.
English: The usual dose is 1 to 2 mg per kg body weight, i.e. 0.2-0.4 ml per kg body weight, given over a period of 5 minutes.
Croatian: Uobičajena doza je 1 do 2 mg na kg tjelesne težine, tj. 0,2-0,4 ml na kg tjelesne težine i primjenjuje se tijekom perioda od 5 minuta.
English: Methylthioninium chloride Proveblue is hypotonic and may be diluted in 50 ml glucose 50 mg/ml (5%) solution for injection to avoid local pain, in particular in paediatric population.
Croatian: Methylthioninium chloride Proveblue je hipotoničan i može se razrijediti u 50 ml otopine glukoze za injekcije 50 mg/ml (5%) da bi se izbjegla lokalna bol, posebice u pedijatrijskoj populaciji.
English: Medac Pharma S.r.l.
Croatian: Magyarország Mediwings Pharma Kft.
English: Laboratoires ETHYPHARM Tel: + 33 1 41 12 65 63
Croatian: Tel: + 33 1 41 12 65 63